Drug Information

Drug General Information
Drug ID
D0I2NX
Former ID
DNC003812
Drug Name
N-Benzyl-2-(toluene-4-sulfonylamino)-benzamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527067]
Formula
C21H20N2O3S
Canonical SMILES
CC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=C2C(=O)NCC3=CC=CC=C3
InChI
1S/C21H20N2O3S/c1-16-11-13-18(14-12-16)27(25,26)23-20-10-6-5-9-19(20)21(24)22-15-17-7-3-2-4-8-17/h2-14,23H,15H2,1H3,(H,22,24)
InChIKey
ASKBFNKCMLTGPX-UHFFFAOYSA-N
PubChem Compound ID
3545567
Target and Pathway
Target(s) Potassium voltage-gated channel subfamily A member 5 Target Info Inhibitor [527067]
PathWhiz Pathway Muscle/Heart Contraction
Reactome Voltage gated Potassium channels
WikiPathways Potassium Channels
References
Ref 527067Bioorg Med Chem Lett. 2004 Jun 7;14(11):2823-7.Pharmacophore-based search, synthesis, and biological evaluation of anthranilic amides as novel blockers of the Kv1.5 channel.
Ref 527067Bioorg Med Chem Lett. 2004 Jun 7;14(11):2823-7.Pharmacophore-based search, synthesis, and biological evaluation of anthranilic amides as novel blockers of the Kv1.5 channel.